Press releases

Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

Sanofi : Availability of the Pre-quarterly Results Communication

Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union

Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents

Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate

Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma

Sanofi and Google to develop new healthcare Innovation Lab

Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments

Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer